169 related articles for article (PubMed ID: 2861661)
1. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
2. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
Beal MF; Benoit R; Mazurek MF; Bird ED; Martin JB
Brain Res; 1986 Mar; 368(2):380-3. PubMed ID: 2870772
[TBL] [Abstract][Full Text] [Related]
4. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
5. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Chattha GK; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Sep; 20(3):282-8. PubMed ID: 3767313
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
[TBL] [Abstract][Full Text] [Related]
8. Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain.
Bergström L; Garlind A; Nilsson L; Alafuzoff I; Fowler CJ; Winblad B; Cowburn RF
J Neurol Sci; 1991 Oct; 105(2):225-33. PubMed ID: 1684616
[TBL] [Abstract][Full Text] [Related]
9. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease.
Krantic S; Robitaille Y; Quirion R
Brain Res; 1992 Feb; 573(2):299-304. PubMed ID: 1354549
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Mazurek MF; Martin JB
Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
[TBL] [Abstract][Full Text] [Related]
11. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
Beal MF; Mazurek MF
Neurology; 1987 Jul; 37(7):1205-9. PubMed ID: 2439949
[TBL] [Abstract][Full Text] [Related]
12. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
Mazurek MF; Beal MF
Neurology; 1991 May; 41(5):716-9. PubMed ID: 1674117
[TBL] [Abstract][Full Text] [Related]
14. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
15. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
[TBL] [Abstract][Full Text] [Related]
16. Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.
Grosser C; Neumann L; Horsthemke B; Zeschnigk M; van de Nes J
Neurosci Lett; 2014 Apr; 566():241-6. PubMed ID: 24602981
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
Neuroscience; 1994 Aug; 61(4):755-64. PubMed ID: 7838375
[TBL] [Abstract][Full Text] [Related]
19. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
Grouselle D; Winsky-Sommerer R; David JP; Delacourte A; Dournaud P; Epelbaum J
Neurosci Lett; 1998 Oct; 255(1):21-4. PubMed ID: 9839717
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
